BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12501005)

  • 1. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    Jpn J Pharmacol; 2002 Dec; 90(4):295-303. PubMed ID: 12501005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80.
    Kobayashi T; Ohta Y; Yoshino J
    Eur J Pharmacol; 2001 Mar; 414(2-3):271-9. PubMed ID: 11239928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
    Biol Pharm Bull; 2006 Apr; 29(4):675-83. PubMed ID: 16595898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
    Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
    Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of teprenone on acute gastric mucosal lesion progression in compound 48/80-treated rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Kitagawa A; Nakazawa S
    Eur J Pharmacol; 2004 Mar; 487(1-3):223-32. PubMed ID: 15033395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    J Pharmacol Sci; 2003 Nov; 93(3):337-46. PubMed ID: 14646252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Nishida K; Ishiguro I
    Dig Dis Sci; 1997 Jun; 42(6):1221-32. PubMed ID: 9201088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kamiya Y; Imai Y; Arisawa T; Nakano H
    Pharmacology; 2005 Jul; 74(4):182-92. PubMed ID: 15855831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Ishiguro I
    Dig Dis Sci; 1999 Sep; 44(9):1865-74. PubMed ID: 10505727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Hayashi T; Inui K; Yoshino J; Nakazawa S
    Phytother Res; 2006 Apr; 20(4):256-62. PubMed ID: 16557606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated recurrence of gastric mucosal lesions in rats after a single treatment with compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():139-48. PubMed ID: 20388957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Ishiguro I
    Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Kobayashi T; Ohta Y; Inui K; Yoshino J; Nakazawa S
    Pharmacol Res; 2002 Jul; 46(1):75-84. PubMed ID: 12208124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of gastric mucosal ascorbic acid in the progression of acute gastric mucosal lesions induced by compound 48/80 in rats.
    Kamiya Y; Ohta Y; Imai Y; Arisawa T; Nakano H
    World J Gastroenterol; 2005 Mar; 11(9):1324-32. PubMed ID: 15761970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebselen, a seleno-organic compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and in vitro systems.
    Tabuchi Y; Sugiyama N; Horiuchi T; Furusawa M; Furuhama K
    Eur J Pharmacol; 1995 Jan; 272(2-3):195-201. PubMed ID: 7713163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrusion process of Acanthopanax senticosus leaves enhances the gastroprotective effect of compound 48/80 on acute gastric mucosal lesion in rats.
    Kim HK; Kim MG; Leem KH
    J Tradit Chin Med; 2016 Apr; 36(2):187-96. PubMed ID: 27400473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cytoprotection by ebselen against the injury induced by necrotizing agents in rats.
    Kurebayashi Y; Tabuchi Y; Akasaki M
    Arzneimittelforschung; 1989 Feb; 39(2):250-3. PubMed ID: 2730695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of coadministered superoxide dismutase and catalase against stress-induced gastric mucosal lesions.
    Ohta Y; Nishida K
    Clin Exp Pharmacol Physiol; 2003 Aug; 30(8):545-50. PubMed ID: 12890175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebselen as protection against ethanol-induced toxicity in rat stomach.
    Unlüçerçi YM; Bulut R; Bekpinar S; Kuntsal L
    J Trace Elem Med Biol; 1999 Nov; 13(3):170-5. PubMed ID: 10612080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size.
    Baljinnyam E; Hasebe N; Morihira M; Sumitomo K; Matsusaka T; Fujino T; Fukuzawa J; Ushikubi F; Kikuchi K
    Hypertens Res; 2006 Nov; 29(11):905-13. PubMed ID: 17345791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.